Proposal of new diagnostic criteria for fatal familial insomnia
© 2022. The Author(s)..
BACKGROUND: The understanding of fatal familial insomnia (FFI), a rare neurodegenerative autosomal dominant prion disease, has improved in recent years as more cases were reported. This work aimed to propose new diagnostic criteria for FFI with optimal sensitivity, specificity, and likelihood ratio.
METHODS: An international group of experts was established and 128 genetically confirmed FFI cases and 281 non-FFI prion disease controls are enrolled in the validation process. The new criteria were proposed based on the following steps with two-round expert consultation: (1) Validation of the 2018 FFI criteria. (2) Diagnostic item selection according to statistical analysis and expert consensus. (3) Validation of the new criteria.
RESULTS: The 2018 criteria for possible FFI had a sensitivity of 90.6%, a specificity of 83.3%, with a positive likelihood ratio (PLR) of 5.43, and a negative likelihood ratio (NLR) of 0.11; and the probable FFI criteria had a sensitivity of 83.6%, specificity of 92.9%, with a PLR of 11.77, and a NLR of 0.18. The new criteria included more specific and/or common clinical features, two exclusion items, and summarized a precise and flexible diagnostic hierarchy. The new criteria for possible FFI had therefore reached a better sensitivity and specificity (92.2% and 96.1%, respectively), a PLR of 23.64 and a NLR of 0.08, whereas the probable FFI criteria showed a sensitivity of 90.6%, a specificity of 98.2%, with a PLR of 50.33 and a NLR of 0.095.
CONCLUSIONS: We propose new clinical diagnostic criteria for FFI, for a better refining of the clinical hallmarks of the disease that ultimately would help an early recognition of FFI and a better differentiation from other prion diseases.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:269 |
|---|---|
| Enthalten in: |
Journal of neurology - 269(2022), 9 vom: 02. Sept., Seite 4909-4919 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chu, Min [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Diagnosis |
|---|
| Anmerkungen: |
Date Completed 11.08.2022 Date Revised 24.08.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00415-022-11135-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM340302593 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM340302593 | ||
| 003 | DE-627 | ||
| 005 | 20231226004833.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00415-022-11135-6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1134.xml |
| 035 | |a (DE-627)NLM340302593 | ||
| 035 | |a (NLM)35501502 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chu, Min |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Proposal of new diagnostic criteria for fatal familial insomnia |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.08.2022 | ||
| 500 | |a Date Revised 24.08.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022. The Author(s). | ||
| 520 | |a BACKGROUND: The understanding of fatal familial insomnia (FFI), a rare neurodegenerative autosomal dominant prion disease, has improved in recent years as more cases were reported. This work aimed to propose new diagnostic criteria for FFI with optimal sensitivity, specificity, and likelihood ratio | ||
| 520 | |a METHODS: An international group of experts was established and 128 genetically confirmed FFI cases and 281 non-FFI prion disease controls are enrolled in the validation process. The new criteria were proposed based on the following steps with two-round expert consultation: (1) Validation of the 2018 FFI criteria. (2) Diagnostic item selection according to statistical analysis and expert consensus. (3) Validation of the new criteria | ||
| 520 | |a RESULTS: The 2018 criteria for possible FFI had a sensitivity of 90.6%, a specificity of 83.3%, with a positive likelihood ratio (PLR) of 5.43, and a negative likelihood ratio (NLR) of 0.11; and the probable FFI criteria had a sensitivity of 83.6%, specificity of 92.9%, with a PLR of 11.77, and a NLR of 0.18. The new criteria included more specific and/or common clinical features, two exclusion items, and summarized a precise and flexible diagnostic hierarchy. The new criteria for possible FFI had therefore reached a better sensitivity and specificity (92.2% and 96.1%, respectively), a PLR of 23.64 and a NLR of 0.08, whereas the probable FFI criteria showed a sensitivity of 90.6%, a specificity of 98.2%, with a PLR of 50.33 and a NLR of 0.095 | ||
| 520 | |a CONCLUSIONS: We propose new clinical diagnostic criteria for FFI, for a better refining of the clinical hallmarks of the disease that ultimately would help an early recognition of FFI and a better differentiation from other prion diseases | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Diagnosis | |
| 650 | 4 | |a Fatal familial insomnia | |
| 650 | 4 | |a Prion disease | |
| 700 | 1 | |a Xie, Kexin |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Jing |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Zhongyun |e verfasserin |4 aut | |
| 700 | 1 | |a Ghorayeb, Imad |e verfasserin |4 aut | |
| 700 | 1 | |a Rupprecht, Sven |e verfasserin |4 aut | |
| 700 | 1 | |a Reder, Anthony T |e verfasserin |4 aut | |
| 700 | 1 | |a Garay, Arturo |e verfasserin |4 aut | |
| 700 | 1 | |a Honda, Hiroyuki |e verfasserin |4 aut | |
| 700 | 1 | |a Nagayama, Masao |e verfasserin |4 aut | |
| 700 | 1 | |a Shi, Qi |e verfasserin |4 aut | |
| 700 | 1 | |a Zhan, Shuqin |e verfasserin |4 aut | |
| 700 | 1 | |a Nan, Haitian |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Jiatang |e verfasserin |4 aut | |
| 700 | 1 | |a Guan, Hongzhi |e verfasserin |4 aut | |
| 700 | 1 | |a Cui, Li |e verfasserin |4 aut | |
| 700 | 1 | |a Guo, Yanjun |e verfasserin |4 aut | |
| 700 | 1 | |a Rosa-Neto, Pedro |e verfasserin |4 aut | |
| 700 | 1 | |a Gauthier, Serge |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Jiawei |e verfasserin |4 aut | |
| 700 | 1 | |a Dong, Xiaoping |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Liyong |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of neurology |d 1974 |g 269(2022), 9 vom: 02. Sept., Seite 4909-4919 |w (DE-627)NLM000508543 |x 1432-1459 |7 nnns |
| 773 | 1 | 8 | |g volume:269 |g year:2022 |g number:9 |g day:02 |g month:09 |g pages:4909-4919 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00415-022-11135-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 269 |j 2022 |e 9 |b 02 |c 09 |h 4909-4919 | ||